U.S. market Closed. Opens in 4 hours 45 minutes

ELAB | Elevai Labs, Inc. Common Stock Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
Revenue1.71M766.28K827.00N/A
Cost of Revenue578.01K324.00K2.85KN/A
Gross Profit1.13M442.27K-2.02KN/A
Operating Expenses1.13M2.23M783.04K222.91K
Selling, General & Admin4.03M1.80M633.96K102.99K
Research & Development426.24K228.75K123.63K118.86K
Other Operating Expenses-3.32M-198.44K-25.45KN/A
Operating Income-3.67M-1.79M-785.06K-221.84K
Other Expenses / Income-632.45K-11.98K321.00-1.07K
Before Tax Income-4.30M-1.80M-784.74K-222.91K
Income Tax ExpensesN/A-2.003.00-1.07K
Net Income-4.30M-1.80M-784.74K-222.91K
Interest Expenses19.52K2.63KN/AN/A
Basic Shares Outstanding10.75M9.53M17.33M4.41M
Diluted Shares Outstanding10.75M9.53M17.33M4.41M
EBITDA-4.27M-1.78M-782.30K-1.07K
EBITDA Margin-249.35%-232.52%-94,594.92%0.00%
EBIT-4.28M-1.80M-784.74K-223.98K
EBIT Margin-250.03%-234.59%-94,889.48%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙